Login
Cart
Support
Search
Search
Search
Amr Aref
Appearances
View Grid
TREATMENT OF RECTAL CANCER BY TOTAL NEOADJUVANT THERAPY AND TRANSANAL LIMITED LOCAL EXCISION FOR COMPLETE RESPONDERS: PHASE II TRIAL RESULTS
Date
May 20, 2024
TOTAL MESORECTAL EXCISION (TME) WITH OR WITHOUT NEOADJUVANT/ADJUVANT THERAPY IS THE STANDARD OF CARE TREATMENT FOR LOCALLY ADVANCED RECTAL CANCER; HOWEVER IT CAN BE ASSOCIATED WITH LONG TERM FREQUENT AND SIGNIFICANT MORBIDITY…
Presenter
Jasneet Bhullar
Speakers
Amer Alame
Ernesto Drelichman
Mohammed Barawi
Amer Zeni
Zyad Kafri
Elon Knoll
Yakan Adli
Wajahat Khan
Amr Aref
CAN TUMOR RESPONSE TO INDUCTION CHEMOTHERAPY PREDICT TME-FREE SURVIVAL AFTER TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER?
Date
May 20, 2024
BACKGROUND: TOTAL NEOADJUVANT THERAPY (TNT) IS RECOGNIZED AS STANDARD OF CARE FOR THE TREATMENT OF LOCALLY ADVANCED RECTAL CANCER (LAR)…
Presenter
Hussein Gharib
Speakers
Susan Szpunar
Zyad Kafri
Elon Knoll
Wajahat Khan
Adli Yakan
Mohammed Barawi
Ernesto Drelichman
Amer Alame
Amer Zeni
Amr Aref